Publications

Breast Events After Treatment of Ductal Carcinoma In Situ in Women: A Population-Based Study.

Chen Q. et al, (2026), Cancer Med, 15

Changing patterns in tongue, oral cavity, laryngeal and hypopharyngeal squamous cell carcinomas in New Zealand: Incidence, trends and survival from 2006 to 2022.

Win Myint TT. et al, (2026), Cancer Epidemiol, 101

Does lifestyle explain the relationship between socioeconomic position and multimorbidity of cancer and cardiometabolic diseases? A mediation analysis applied to the European Prospective Investigation into Cancer and Nutrition.

Manfredi L. et al, (2025), J Epidemiol Community Health, 80, 3 - 9

Trends and disparities in locoregional treatment of programme-detected ductal carcinoma in situ in New Zealand women, 1999-2022.

Chen Q. et al, (2025), Cancer Epidemiol, 99

Disparities in time to breast cancer surgery in New Zealand by level of neighbourhood deprivation: a population-based study.

Boyle L. et al, (2025), Cancer Causes Control, 36, 1499 - 1510

Prospective evaluation of circulating plasma thyroid hormones concentrations and breast cancer risk in the EPIC cohort.

His M. et al, (2025), EBioMedicine, 121

Lifestyle changes and postmenopausal breast cancer risk in women from the European Prospective Investigation into Cancer and Nutrition.

Vasson F. et al, (2025), Breast Cancer Res, 27

Statin use and breast cancer-specific mortality and recurrence: a systematic review and meta-analysis including the role of immortal time bias and tumour characteristics.

Scott OW. et al, (2025), Br J Cancer, 133, 539 - 554

The effects of adjuvant endocrine therapy on long-term outcomes from ductal carcinoma in situ: a systematic review and meta-analysis.

Chen Q. et al, (2025), Breast, 82

Associations between commuting modes and risk of 16 site-specific cancers in the UK Biobank.

Thu W. et al, (2025), Int J Epidemiol, 54

Beta blocker use and breast cancer survival by subtypes: A population-based cohort study.

Scott OW. et al, (2025), Breast, 81

Development and validation of a risk prediction model for premenopausal breast cancer in 19 cohorts.

Brantley KD. et al, (2025), Breast Cancer Res, 27

Reproductive Factors, Sex Hormone Levels, and Differentiated Thyroid Cancer Risk: A Mendelian Randomization Study.

Park SH. et al, (2025), Thyroid, 35, 433 - 443

Incidence trends of ductal carcinoma in situ in New Zealand women between 1999 and 2022.

Chen Q. et al, (2025), Breast Cancer Res Treat, 210, 439 - 449

Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor-Mutated Nonsquamous Non-Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort Study.

Aye PS. et al, (2025), JMIR Cancer, 11

Search results (94)